Product image of Pantoprazolo Mylan (Pantoprazole Sodium Sesquihydrate) supplied by GNH India

Pantoprazolo Mylan

Active Ingredient:
Pantoprazole Sodium Sesquihydrate
Origin:
EU

Pantoprazolo Mylan (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazolo Mylan, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults.

GNH India supplies Pantoprazolo Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mylan S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Pantoprazolo Mylan, a proton pump inhibitor, is indicated for conditions involving excess gastric acid secretion.

  • Gastro‑esophageal reflux disease (GERD): provides symptomatic relief by healing esophageal irritation and reducing reflux episodes.
  • Erosive esophagitis: promotes healing of acid‑induced esophageal lesions and prevents recurrence.
  • Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with gastrin‑producing tumors.
  • NSAID‑induced gastric ulcer prevention: reduces risk of ulcer formation in patients requiring long‑term non‑steroidal anti‑inflammatory therapy.

How It Works

  • Pantoprazole sodium sesquihydrate selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid production, it markedly lowers both basal and stimulated gastric acidity, allowing damaged mucosa to heal and reducing reflux.

Side Effects

Pantoprazolo Mylan may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Diarrhea: loose stools, often transient.
  • Nausea: feeling of queasiness.
  • Abdominal pain: discomfort in the stomach area.
  • Flatulence: increased intestinal gas.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing.
  • Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping.
  • Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
  • Bone fractures: increased risk with long‑term use.
  • Acute interstitial nephritis: kidney inflammation, reduced urine output.

Precautions & Warnings

Before prescribing Pantoprazolo Mylan, clinicians should consider several safety and handling precautions.

  • Assess renal function: dose adjustment may be needed in severe renal impairment.
  • Evaluate for liver disease: monitor hepatic enzymes in patients with hepatic impairment.
  • Long‑term use caution: consider risk of osteoporosis‑related fractures with prolonged therapy.
  • Monitor magnesium: periodic assessment recommended for patients on extended treatment.
  • Avoid abrupt discontinuation: taper may be required to prevent rebound acid hypersecretion.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Avoid Interactions

Pantoprazolo Mylan can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

  • Ketoconazole or itraconazole: reduced antifungal absorption; avoid concurrent use.
  • Atazanavir or nelfinavir: decreased antiviral efficacy; contraindicated.
  • Clopidogrel: diminished antiplatelet effect; consider alternative therapy.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR; monitor coagulation parameters.
  • Digoxin: elevated serum levels; check digoxin concentrations.
  • Methotrexate (high dose): reduced renal clearance; monitor for toxicity.
  • Iron supplements: decreased iron absorption; separate dosing by at least 2 hours.

Frequently Asked Questions

Pantoprazolo Mylan contains pantoprazole, a proton pump inhibitor that reduces gastric acid secretion. It is prescribed for conditions such as gastro‑esophageal reflux disease, erosive esophagitis, Zollinger‑Ellison syndrome, and for the prevention of NSAID‑related gastric ulcers.

Pantoprazole blocks the H+/K+‑ATPase enzyme, also known as the gastric proton pump, on the surface of stomach parietal cells. By irreversibly inhibiting this final step of acid production, it lowers both basal and stimulated gastric acidity, allowing damaged tissue to heal.

The appropriate dose of Pantoprazolo Mylan is determined by the prescribing clinician based on the specific indication, patient age, renal function and treatment duration. Typical adult regimens range from 20 mg to 40 mg once daily, but exact dosing should follow the prescriber’s order.

Pantoprazole is classified as pregnancy category B in the EU, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy only if the potential benefit justifies the risk. Limited data are available for lactating women; the decision should be made by the healthcare provider.

To request Pantoprazolo Mylan, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Pantoprazolo Mylan and other PPIs like omeprazole share the same mechanism of inhibiting the gastric proton pump, but they differ in pharmacokinetic profiles. Pantoprazole has a lower potential for drug‑drug interactions mediated by CYP2C19, making it a preferred option for patients on multiple medications.

Pantoprazolo Mylan should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Pantoprazolo Mylan is supplied as an oral tablet and is taken by mouth, usually once daily in the morning before a meal. The tablet should be swallowed whole with water; it should not be crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious but rare adverse events linked to pantoprazole include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhea, hypomagnesemia, acute interstitial nephritis, and an increased risk of bone fractures with long‑term use. Patients should be monitored for these conditions, especially during extended therapy.

Pantoprazolo Mylan is contraindicated in patients with known hypersensitivity to pantoprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, those taking medications that require an acidic environment for absorption, and patients with a history of osteoporosis when used long‑term.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Pantoprazole Sodium Sesquihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT